The Week In Review: Manufacturing

GF-IBM deal near; Intel’s record fine; SEMI’s book-to-bill; Applied’s genes.


In a much-anticipated deal, IBM is close to selling its chip unit to GlobalFoundries, according to Bloomberg. GlobalFoundries wants IBM’s engineers and the IP, and not the fabs.

Intel lost its challenge against a record 1.06 billion euro ($1.44 billion) European Union fine handed down five years ago, according to Reuters. The EU said Intel tried to thwart AMD by giving rebates to PC makers.

SEMI reported that worldwide semiconductor manufacturing equipment billings reached $10.15 billion in the first quarter of 2014. The billings figure is 9% higher than the fourth quarter of 2013 and 39% higher than the same quarter a year ago.

Applied Ventures, the venture capital arm of Applied Materials, has participated in a Series B financing round for Twist Bioscience, a company developing a proprietary semiconductor-based technology platform for synthetic gene manufacturing.

Lam Research announced that the Lam Research Foundation, the company’s charitable giving organization, has made a one-time gift of $1 million to six non-profits groups.

ON Semiconductor signed a definitive agreement to acquire Aptina Imaging, a provider of CMOS image sensors for the automotive and industrial markets.

Analog Devices will acquire RF component maker Hittite for $78 per share in cash.

Renesas continues to restructure. The company announced its decision to transfer all of its shares in Renesas SP Drivers to Synaptics.

A team of researchers from Purdue University, Sematech and SUNY College of Nanoscale Science and Engineering presented work involving high-performance molybdenum disulfide (MoS2) field-effect transistors (FETs).

Except for November, DRAM average selling prices increased each month of 2013, according to IC Insights. Moreover, in February of 2014, the DRAM ASP reached $3.19, its highest level since February of 2007. Is DRAM surge over?

Leave a Reply

(Note: This name will be displayed publicly)